Immunocore Retained Earnings vs Other Assets Analysis
IMCR Stock | USD 58.95 0.90 1.50% |
Immunocore Holdings financial indicator trend analysis is infinitely more than just investigating Immunocore Holdings recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunocore Holdings is a good investment. Please check the relationship between Immunocore Holdings Retained Earnings and its Other Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.
Retained Earnings vs Other Assets
Retained Earnings vs Other Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunocore Holdings Retained Earnings account and Other Assets. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Immunocore Holdings' Retained Earnings and Other Assets is -0.28. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Other Assets in the same time period over historical financial statements of Immunocore Holdings, assuming nothing else is changed. The correlation between historical values of Immunocore Holdings' Retained Earnings and Other Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Immunocore Holdings are associated (or correlated) with its Other Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Assets has no effect on the direction of Retained Earnings i.e., Immunocore Holdings' Retained Earnings and Other Assets go up and down completely randomly.
Correlation Coefficient | -0.28 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Other Assets
Most indicators from Immunocore Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunocore Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.At this time, Immunocore Holdings' Tax Provision is relatively stable compared to the past year. As of 05/13/2024, Enterprise Value is likely to grow to about 3.5 T, while Selling General Administrative is likely to drop slightly above 84.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 47K | 3.2M | 4.1M | 4.7M | Interest Income | 47K | 3.2M | 12.5M | 13.1M |
Immunocore Holdings fundamental ratios Correlations
Click cells to compare fundamentals
Immunocore Holdings Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immunocore Holdings fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 5.1M | 20.1M | 39K | 51K | 114.3M | 120.0M | |
Total Current Liabilities | 84.5M | 55.0M | 61.2M | 83.1M | 139.0M | 72.0M | |
Other Liab | 48.1M | 25.0M | 6.5M | 5.9M | 5.3M | 5.1M | |
Net Tangible Assets | 14.8M | 55.3M | 171.5M | 278.3M | 320.1M | 336.1M | |
Retained Earnings | (279.1M) | (349.9M) | (481.4M) | (261.3M) | (744.7M) | (707.4M) | |
Accounts Payable | 15.7M | 5.8M | 35.4M | 75.1M | 17.8M | 23.0M | |
Other Assets | 6.5M | 7.2M | 7.5M | 11.6M | 10.4M | 7.5M | |
Net Receivables | 50.0M | 23.2M | 24.8M | 58.4M | 61.4M | 40.2M | |
Other Stockholder Equity | 293.9M | 405.1M | 266.6M | 205.2M | 1.1B | 1.2B | |
Total Current Assets | 124.3M | 152.9M | 262.7M | 391.9M | 528.8M | 270.4M | |
Property Plant Equipment | 54.9M | 36.8M | 31.5M | 31.6M | 36.4M | 33.1M | |
Other Current Assets | 48.8M | 21.2M | 18.8M | 58.4K | 9.7M | 12.3M | |
Total Assets | 185.6M | 197.2M | 301.8M | 435.5M | 597.0M | 350.7M | |
Short Long Term Debt Total | 59.4M | 63.9M | 63.8M | 69.3M | 84.0M | 65.9M | |
Total Stockholder Equity | 14.8M | 55.3M | 171.5M | 278.8M | 368.8M | 387.3M | |
Property Plant And Equipment Net | 54.9M | 36.8M | 31.5M | 31.6M | 42.7M | 40.1M | |
Net Debt | (14.6M) | (65.8M) | (174.1M) | (263.2M) | (358.6M) | (340.7M) | |
Cash | 74.0M | 129.7M | 237.9M | 332.5M | 442.6M | 245.9M | |
Non Current Assets Total | 61.4M | 44.3M | 39.0M | 43.6M | 68.2M | 51.5M | |
Non Currrent Assets Other | 4.4M | 4.2M | (31.5M) | 7.2M | 14.5M | 15.2M | |
Cash And Short Term Investments | 74.0M | 129.7M | 237.9M | 332.5M | 442.6M | 245.9M | |
Liabilities And Stockholders Equity | 185.6M | 197.2M | 301.8M | 435.5M | 597.0M | 350.7M | |
Non Current Liabilities Total | 86.4M | 86.9M | 69.0M | 73.7M | 89.1M | 66.0M | |
Capital Lease Obligations | 40.3M | 27.2M | 26.6M | 29.8M | 36.0M | 29.3M | |
Inventory | (48.6M) | (21.2M) | (18.8M) | 943K | 4.5M | 4.7M | |
Total Liab | 170.9M | 141.8M | 130.2M | 156.8M | 228.2M | 177.3M | |
Net Invested Capital | 33.9M | 92M | 208.8M | 318.3M | 416.9M | 210.0M | |
Long Term Investments | 591K | 973K | 165K | 137K | 123.3K | 117.1K | |
Property Plant And Equipment Gross | 54.9M | 36.8M | 31.5M | 31.6M | 95.0M | 49.7M | |
Accumulated Other Comprehensive Income | (32K) | 163K | 386.3M | 334.8M | (36.3M) | (34.4M) | |
Net Working Capital | 39.8M | 97.9M | 201.5M | 308.8M | 389.8M | 212.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.Note that the Immunocore Holdings information on this page should be used as a complementary analysis to other Immunocore Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Immunocore Stock analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Transaction History View history of all your transactions and understand their impact on performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Immunocore Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunocore Holdings. If investors know Immunocore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunocore Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (1.42) | Revenue Per Share 5.102 | Quarterly Revenue Growth 0.122 | Return On Assets (0.07) |
The market value of Immunocore Holdings is measured differently than its book value, which is the value of Immunocore that is recorded on the company's balance sheet. Investors also form their own opinion of Immunocore Holdings' value that differs from its market value or its book value, called intrinsic value, which is Immunocore Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunocore Holdings' market value can be influenced by many factors that don't directly affect Immunocore Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunocore Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunocore Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunocore Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.